cyclosporine and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

cyclosporine has been researched along with Chronic Inflammatory Demyelinating Polyradiculoneuropathy in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (41.67)29.6817
2010's5 (41.67)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Chae, JH; Choi, J; Choi, SA; Hwang, H; Kim, H; Kim, KJ; Kim, SY; Kim, W; Lim, BC; Shim, YK1
Kira, J; Kusunoki, S; Kuwahara, M; Ogata, H; Sato, D; Suzuki, Y1
Alsharabati, M; King, P; Lu, L; Morgan, MB; Oh, SJ1
Alimoghaddam, K; Khodabakhsh, A; Nafissi, S; Sinaei, F1
Ajlan, RS; Champion, M; Herrera, I; Kam, Y; Whittaker, TJ1
Antonini, G; Benedetti, L; Briani, C; Cocito, D; Falcone, Y; Fazio, R; Grimaldi, S; Jann, S; Matà, S; Nobile-Orazio, E; Paolasso, I; Sabatelli, M1
Hirotani, M; Horiuchi, K; Kano, T; Matsushima, M; Matumoto, A; Sasaki, H; Shirai, S; Takahashi, I; Takeuchi, A; Yabe, I1
Hughes, RA; Swan, AV; van Doorn, PA2
Gono, T; Hoshi, K; Ikeda, S; Matsuda, M; Morita, H1
Hirata, K; Odaka, M; Susuki, K; Tatsumoto, M; Yuki, N1
Chiemchanya, S; Visudhiphan, P; Visudtibhan, A1

Reviews

2 review(s) available for cyclosporine and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

ArticleYear
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    The Cochrane database of systematic reviews, 2003, Issue:1

    Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Interferon-beta; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic; Steroids

2003
Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    The Cochrane database of systematic reviews, 2004, Oct-18, Issue:4

    Topics: Anti-Inflammatory Agents; Azathioprine; Cyclophosphamide; Cyclosporine; Humans; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Interferon-beta; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Randomized Controlled Trials as Topic; Steroids

2004

Trials

1 trial(s) available for cyclosporine and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

ArticleYear
Cyclosporin A in treatment of refractory patients with chronic inflammatory demyelinating polyradiculoneuropathy.
    Journal of the neurological sciences, 2004, Sep-15, Volume: 224, Issue:1-2

    Topics: Administration, Oral; Adult; Antirheumatic Agents; Cyclosporine; Disability Evaluation; Dose-Response Relationship, Drug; Evoked Potentials; Female; Humans; Male; Median Nerve; Middle Aged; Muscle, Skeletal; Neural Conduction; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Proteins; Statistics, Nonparametric; Tibial Nerve; Time Factors; Treatment Outcome

2004

Other Studies

9 other study(ies) available for cyclosporine and Chronic Inflammatory Demyelinating Polyradiculoneuropathy

ArticleYear
Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases.
    Neuromuscular disorders : NMD, 2019, Volume: 29, Issue:9

    Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methylprednisolone; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Failure; Treatment Outcome

2019
[A case of neurofascin-155 antibody-positive chronic inflammatory demyelinating polyradiculoneuropathy successfully treated with Cyclosporine A].
    Rinsho shinkeigaku = Clinical neurology, 2020, Aug-07, Volume: 60, Issue:8

    Topics: Adult; Autoantibodies; Biomarkers; Cell Adhesion Molecules; Cyclosporine; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Male; Nerve Growth Factors; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

2020
Chronic inflammatory axonal polyneuropathy.
    Journal of neurology, neurosurgery, and psychiatry, 2020, Volume: 91, Issue:11

    Topics: Adolescent; Adult; Aged; Autoimmune Diseases of the Nervous System; Axons; Azathioprine; Biopsy; Child; Child, Preschool; Chronic Disease; Cyclophosphamide; Cyclosporine; Electromyography; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Inflammation; Male; Middle Aged; Mycophenolic Acid; Neural Conduction; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Sural Nerve; Young Adult

2020
Delayed-onset inflammatory polyneuropathy without graft versus host disease after bone marrow transplantation.
    Muscle & nerve, 2018, Volume: 58, Issue:2

    Topics: Anti-Inflammatory Agents; Bone Marrow Transplantation; Cyclosporine; Demyelinating Diseases; Female; Graft vs Host Disease; Humans; Immunization, Passive; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Middle Aged; Multiple Myeloma; Polyneuropathies; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Young Adult

2018
Bisphosphonate-induced orbital inflammation in a patient on chronic immunosuppressive therapy.
    BMC ophthalmology, 2019, Feb-14, Volume: 19, Issue:1

    Topics: Administration, Oral; Bone Density Conservation Agents; Cyclosporine; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Orbital Pseudotumor; Osteoporosis, Postmenopausal; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisone; Sjogren's Syndrome; Zoledronic Acid

2019
Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    European journal of neurology, 2011, Volume: 18, Issue:12

    Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Axons; Azathioprine; Child; Cyclophosphamide; Cyclosporine; Drug Resistance; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Interferon beta-1a; Interferon-alpha; Interferon-beta; Italy; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Remission Induction; Retrospective Studies; Rituximab; Severity of Illness Index; Treatment Outcome; Young Adult

2011
[Successful cyclosporine treatment in 2 patients with refractory CIDP, involving monitoring of both AUC(0-4h) and trough levels].
    Rinsho shinkeigaku = Clinical neurology, 2012, Volume: 52, Issue:3

    Topics: Adult; Antifungal Agents; Area Under Curve; Cyclosporine; Female; Humans; Male; Middle Aged; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

2012
Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin.
    Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:8

    Topics: Administration, Oral; Adult; Aged; Algorithms; Antirheumatic Agents; Cerebrospinal Fluid Proteins; Child; Chronic Disease; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunoglobulins, Intravenous; Male; Middle Aged; Peripheral Nerves; Plasma Exchange; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Prednisolone; Pulse Therapy, Drug; Treatment Outcome

2005
Cyclosporine in chronic inflammatory demyelinating polyradiculoneuropathy.
    Pediatric neurology, 2005, Volume: 33, Issue:5

    Topics: Child, Preschool; Cyclosporine; Female; Humans; Immunosuppressive Agents; Muscle Weakness; Neural Conduction; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating

2005